Science ❯Medical Research ❯Clinical Trials
Pharmaceuticals Cardiology Risk Factors Disease Burden Patient Experiences Preventive Medicine Innovative Therapies Clinical Trials Clinical Guidelines Genetics
The siRNA-based drug shows promise as the first treatment for high lipoprotein(a) levels, with Phase 3 trials underway to assess its impact on cardiovascular events.
